Synthesis method of selenium cyanided isoquinolinone

CN118930483AActive Publication Date: 2024-11-12XINJIANG UNIVERSITY
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202410173669.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-02-07
Publication Date
2024-11-12
Estimated Expiration
2044-02-07

Smart Images

  • Figure CN118930483A_ABST
    Figure CN118930483A_ABST
Patent Text Reader

Abstract

The invention discloses a method for synthesizing 2, 4, 5-trimethyl-1, 3-pentanediol through free radical addition tandem cyclization reaction of N aryl acryloyl benzamide or 2-aryl-N-acryloyl indole or N-methylacryloyl-2-phenylbenzimidazole and potassium selenide under visible light conditions, cheap KSeCN as a selenium cyaniding reagent, potassium persulfate as an oxidizing agent, 2, 4, 5-trimethyl-1, 3-pentanediol and the like, and a preparation method of the 2, 4, 5-trimethyl-1, 3-pentanediol. 2, 6-triphenyltetrafluoroborate and the like are used as phase-transfer catalysis and photocatalysis bifunctional catalysts, and a selenide cyclization reaction is carried out. According to the reaction, under the conditions of room temperature and visible light, selenium cyanided isoquinoline-1, 3 (2H, 4H)-diketone, indole [2, 1-a] isoquinolinone and benzimidazole [2, 1-a] isoquinolin-6 (5H)-ketone are synthesized at medium to excellent yield. The method has the advantages of mild reaction conditions, good substrate compatibility, large-scale synthesis, simple operation, cheap and easily available raw materials, simple preparation, stable structure and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention discloses a tandem cyclization reaction of N-aryl acryloyl benzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole with potassium selenocyanate under green and environmentally friendly visible light conditions. This synthetic method for converting into a selenocyanated isoquinolinedione or indole [2,1-a] isoquinolinone or benzimidazole [2,1-a] isoquinolin-6 (5H) -one compound provides a convenient route, using cheap KSeCN as a selenocyanation reagent, potassium persulfate as an oxidant, and 2,4,6-triphenyl tetrafluoroborate as a phase transfer catalyst and a photocatalytic bifunctional catalyst, to carry out a selenocyanation reaction, with a wide range of substrates. The advantages of the invention include: mild conditions, green reaction without transition metal catalysts, simple operation; cheap and readily available raw materials, a wide range of sources, simple preparation, and stable structure. Background Art

[0002] Isoquinoline-1,3(2H,4H)-dione compounds and their derivatives are an important class of nitrogen-containing heterocyclic compounds, which are widely found in natural products, drug molecules and organic functional materials. These bioactive molecules include HIV-1 integrase inhibitors, aldose reductase inhibitors, progesterone receptor antagonists, anti-tumor drugs, etc. (Billamboz, M.; Bailly, F.; Lion, C.; Touati, N.; Vezin, H.; Calmels, C.; Andreola, ML; Christ, F., Debyser, Z.; and Cotelle, PJMed. Chem. 2011, 54, 1812-1824 .Mayer, SC; Banker, AL; Boschelli, F.; Li, D.; Johnson, M.; Kenny, CH; Krishnamurthy, G.; Kutterer, K.; Moy, F.; Petusky, S.; Ravi, M.; Tkach, D.; Tsouc, HR; and Wei,XXBioorg.Med.Chem.Lett.2008,18,3641-3645.Nakagawa,A.;Uno,S.;Makishima,M.;Miyachi,H.;and Hashimoto, Y.; Bioorg. Med. Chem. 2008, 16, 7046-7054. Billamboz, M.; Suchaud, V.; Bailly, F.; Lion, C.; Demeulemeester, J.; Calmels, C.; Andreola, 'ML; Christ, F.; Debyser, Z.; and Cotelle. P.; ACS Med. Chem. Lett. 2013, 4, 606-611.) Indole [2,1-a] isoquinolinone compounds are widely present in biologically active and drug molecules.(Kraus, G.A.; Gupta, V.; Kohut, M.; Singh, N.; Bioorg.Med.Chem.Lett., 2009, 19, 5539-5542. Alam, K.; Hong, S.W.; Oh, K.H.; Park, J.K.; Angew.Chem.Int.Ed., 2017, 56, 13387-13391. Goldbrunner, M.; Loidl, G.; Polossek, T.; Mannschreck, A.; Angerer, E.von; J.Med.Chem., 1997, 40, 3 524-3533.Ambros,R.;Schneider,MR;Angerer,S.von.;J.Med.Chem.,1990,33,153-160.Wang,S.;Wang,JS;Ying,J.;Wu,XFChin.Chem.Let t.,2023,34,107873.Zhai,SX;Qiub,SX;Yang,S.;Hua,BY;Niu,YS;Ha n,CC;Yu,YZ;Li,YC;Zhai,HB;Chin.Chem.Lett.,2022,33,276-279.)。

[0003] In the past decade, research on the use of N-aryl acryloylbenzamide, 2-aryl-N-acryloylindole, or N-methacryloyl-2-phenylbenzimidazole compounds as substrates to construct isoquinolinone skeletons through free radical addition and cyclization reactions has attracted widespread attention. Due to the special chemical structure of N-aryl acryloylbenzamide, 2-aryl-N-acryloylindole, or N-methacryloyl-2-phenylbenzimidazole compounds, they can produce free radicals to initiate rapid ring closure without polymerization, making them a method for synthesizing isoquinolinediones, 2-aryl-N-acryloylindole, or benzimidazolo[2,1-a]isoquinolin-6(5H)-one compounds through free radical addition and cyclization. Traditional methods for synthesizing isoquinolinedione or indole[2,1-a]isoquinolinone or benzimidazolo[2,1-a]isoquinolin-6(5H)-one compounds (Tang, QJ; Xie, P.; Wang, J.; Lin, JJ; Feng, CL; Pittman Jr. CU; Zhou, AH; Tetrahedron., 2017, 73, 5436-5443. Huang, SH; Niu, PF; Su, YP; Hu, DC; and Huo, CD Org. Biomol. Chem., 2018, 16, 7748-7752. Chen, YJ; He, YH; Guan, Z.; Tetrahedron., 2019, 75, 3053-3061. Zou, GL; and Wang.XL; Org.Biomol.Chem., 2017, 15, 8748-8754. Pan, Y.; Beilstein J. Org. Chem. 2016, 12, 301-308. Li, J.; Wang, ZG; Wu, NJ; Gao, G.; and You, JS; Chem. Commun., 2014, 50, 15049-15051. Ge, YX; Tian, ​​YF; Wu, JL; Yan, QQ; Zheng, LP; Ren, YM; Zhao, JC; and Li, ZJ; Chem. Commun., 2020, 56, 12656-12659. Li, JZ; Mei, L.; Cai, XE; Zhang, CC; Cao, TT; Huang, XJ;Liu,YL;and Wei,WT;Adv.Synth.Catal.,2022,364,2080-2085.Cui,HH;Niu,CH;and Zhang.C.;J.Org.Chem.2021,86,15835-15844.Wei,YL;Chen,JQ;Sun,B.;and Xu, PF; Chem. Commun., 2019, 55, 5922-5925. Zeng, FL; Zhu, HL; Chen, XL; Qu, LB; and Yu, B.; Green Chem., 2021, 23, 3677-3682. Ma, N.; Guo, L.; Shen, Z. J.; Qi, D.; Yang, C.; and Xia, W. J. Org. Biomol. Chem., 2022, 20, 1731-1737.) The above methods generally have the disadvantages of requiring high temperature conditions, transition metal catalysts, expensive ligands, and a narrow substrate range. The present invention uses cheap and readily available N-aryl acryloyl benzamide or 2-aryl-N-acryloyl indole or N-methyl acryloyl-2-phenylbenzimidazole compounds as raw materials under visible light conditions to efficiently synthesize selenocyanate-substituted isoquinolinedione or indole [2,1-a] isoquinolinone or benzimidazole [2,1-a] isoquinolin-6 (5H) -one compounds. The reaction operation is simple, environmentally friendly, carried out at room temperature, and no transition metal is required. . Summary of the invention

[0004] The purpose of the present invention is to provide a method with easy-to-obtain raw materials, simple operation, mild reaction conditions, and environmental protection, using cheap KSeCN as a selenocyanation reagent, potassium persulfate as an oxidant, and a photocatalytic bifunctional catalyst as a phase transfer catalysis to carry out a selenocyanation reaction. To prepare selenocyanated isoquinolinedione or indole [2,1-a] isoquinolinone or benzimidazolo [2,1-a] isoquinolin-6 (5H) -one compounds. In order to achieve the above purpose, the technical scheme of the present invention is as follows:

[0005] Under visible light conditions, N-aryl acryloylbenzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole compound (Ⅰ) reacts with potassium selenocyanate (Ⅱ) at room temperature to undergo a free radical tandem cyclization reaction (reaction formula 1). After the reaction, the product is separated and characterized by conventional separation and purification methods to obtain the corresponding selenocyanide isoquinolinedione or indole [2,1-a] isoquinolinone or benzimidazolo [2,1-a] isoquinolin-6 (5H) -one compound (Ⅲ).

[0006] The structure of selenocyanate-substituted isoquinolinediones or indole[2,1-a]isoquinolinones is as follows:

[0007]

[0008] R 1 , R 3 Each independently represents a substituent at one or more different positions of the benzene ring, such as the ortho position, the meta position, the para position, etc., or a hydrogen-free substituent, and the substituent R 1 is H, halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, fluoroalkyl C n F m H, n is 1-4, m is one or more of 1-4, the number of substituents is 1-5; halogen is one or more of F, Cl, Br or I; the substituent R 2 is an alkyl group having 1 to 4 carbon atoms, an alkyl group having 15 to 20 carbon atoms, a cycloalkyl group having 3 to 7 carbon atoms, a phenyl group, or an aryl group containing a substituent, wherein the substituent is an alkyl group or a fluoroalkyl group having 1 to 4 carbon atoms, a fluoroalkyl group C n F m H, n is 1-4, m is one or more of 1-4; substituent R 3 It is one or more of H, CH3 or halogen, the halogen is one or more of F, Cl, Br or I, and the number of substituents is 1-5.

[0009] Wherein, the reaction process is shown in the following reaction formula;

[0010]

[0011] The substituent R 1 and the substituent R 3 Same as above;

[0012] The dotted line in N-aryl acryloyl benzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole (I) indicates that there is no benzene ring or there is a benzene ring. When there is no benzene ring and X=O, n=1,2, etc., it is N-aryl acryloyl benzamide; when there is a benzene ring and X=C, n=0, it is 2-aryl-N-acryloyl indole; when there is no benzene ring above X and X=N, n=0, it is N-methacryloyl-2-phenylbenzimidazole; and selenocyanidin or indole [2 ,1-a]isoquinolinone or benzimidazolo[2,1-a]isoquinolin-6(5H)-one (III) in which the dotted line indicates that there are three situations: compounds with or without a benzene ring. When there is no benzene ring and X=O, n=1,2,etc, it is a selenocyanided isoquinolinedione; when there is a benzene ring and X=C, n=0, it is a selenocyanided indole[2,1-a]isoquinolinone compound; when there is no benzene ring above X and X=N, n=0, it is a selenocyanided benzimidazolo[2,1-a]isoquinolin-6(5H)-one compound.

[0013] As shown in the above reaction formula, the present invention uses blue light as a light source under room temperature conditions, and uses N-aryl acryloylbenzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole compound (I) and potassium selenocyanate (II) to achieve visible light-induced free radical tandem cyclization reaction at room temperature to generate selenocyanide isoquinolinedione or 2-indole [2,1-a] isoquinolinone or benzimidazolo [2,1-a] isoquinolin-6 (5H) -one compound (III).

[0014] In the present invention, the reaction is carried out under the irradiation of white light (6500K), purple light (400-405nm), blue light (460-465nm), green light (526-531nm) or red light (700-705nm), with 12W blue light (460-465nm) being the best, and the reaction light source is 460-465nm blue light.

[0015] In the present invention, in the reaction, the solvent is one or more of acetonitrile, dichloromethane, water, dichloromethane / water (volume ratio is 4:1-1:4), methanol, N,N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide and 1,2-dichloroethane, and the reaction solvent is dichloromethane / water (volume ratio is 1:1). The concentration of the N-(hetero)aryl acrylamide compound is 0.1-0.3M, and the optimal concentration is 0.1M.

[0016] In the present invention, in the reaction, the oxidant is any one or two of N-chlorosuccinimide, dibenzoyl peroxide, oxygen, potassium persulfate, tert-butyl perbenzoate, and di-tert-butyl peroxide, and the reaction oxidant is potassium persulfate; the concentration of the base in the solvent is 0.05-0.2M, preferably 0.125-0.2M, and most preferably 0.2M.

[0017] In the present invention, the reaction is carried out in the presence of a bifunctional catalyst, which is any one or two of PC1, PC2, PC3, and PC4, and the preferred bifunctional catalyst is PC2; the optimal concentration of the bifunctional catalyst in the solvent is 0.001M.

[0018]

[0019] In the present invention, the preferred molar ratio of the N-aryl acryloyl benzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole compound (I) to potassium selenocyanate (II) in the reaction is 1:1-1:3, and the optimal molar ratio is 1:1.5. The concentration of the N-aryl acryloyl benzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole compound in the reaction solvent is 0.1M, and the concentration of potassium selenocyanate in the reaction solvent is 0.15M.

[0020] In the present invention, the reaction time in the reaction is 12-24 hours. Preferably, the reaction time is 12 hours.

[0021] The synthesis reaction of the present invention comprises the following steps:

[0022] Synthesis of N-methacryloylbenzamide:

[0023]

[0024] According to the previous preparation literature report (J.Xu, Z.Yang, J.-W.Hua., Org.Chem.Front., 2020, 7, 3223-3228.), compound A was added with primary amine (15mmol), Et3N (20mmol) and DCM (20mL) in a 100mL round-bottom flask, the reaction mixture was cooled to 0°C, and then benzoyl chloride (10mmol) was slowly added dropwise. Stir at room temperature for 4-6 hours, then the reaction was completed under TLC monitoring, the organic phase was separated, dried over Na2SO4, and concentrated in vacuo. The obtained residue was purified by flash silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 1: 1) in a yield of 93-95%.

[0025] N-methylbenzamide (10 mmol), DMAP (1 mmol), triethylamine (20 mmol), and dichloromethane (20 mL) were added to a 100 mL round-bottom flask, and the reaction mixture was cooled to 0°C, and methacryloyl chloride was slowly added to the reaction mixture. Then, the mixture was stirred at room temperature for 4-6 hours, and the reaction was completed under TLC monitoring. The organic phase was separated, dried over Na2SO4, and concentrated in vacuo. The obtained residue was purified by flash silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 3:1) to obtain the desired product 1a in a yield of 74-85%.

[0026]

[0027] Or, Synthesis of Compound D:

[0028] According to the previous preparation literature report (Y. Yuan, Y. Zheng, B. Xu, et al., ACS Catal. 2020, 10, 6676-6681.), a mixture of substituted phenylhydrazine hydrochloride (2.0 mmol, 2.0 equiv) and acetic acid was added to a 250 mL round-bottom flask and stirred for 30 minutes under a N2 atmosphere at 50 ° C, and then the substituted ketone (1.0 mmol, 1.0 equiv) was added to the solution, heated to 130 ° C, and the reaction mixture was cooled after 8 hours of reaction. Water was added and the mixture was stirred at 0 ° C to obtain a precipitate. Then, the obtained crude solid indole compound D can be directly used in the next step of synthesis after drying. Sometimes, the obtained crude solid should be purified by column chromatography to obtain indole compound D.

[0029] Synthesis of 2-aryl-N-acryloyl indole:

[0030] According to the modified literature procedure, DCM (10 mL), indole D (5 mmol, 1 equiv) and DMAP (2.0 mmol, 0.4 equiv) were added to a 100 ml round-bottom flask and then Et3N (10 mmol, 2.0 equiv) was added to the mixed solution at 0 °C. Then, methacryloyl chloride (10 mmol, 2.0 equiv) was slowly dropped into the solution, and the solution was warmed to room temperature and stirred for 2-3 days. The mixture was diluted with DCM (20 mL) and saturated NH4Cl solution (20 mL). The organic layer and the aqueous layer were separated. The aqueous layer was extracted with DCM (20 mL × 3 times). The combined organic layers were washed with brine and dried over Na2SO4. After evaporation of the solvent, the crude product 1ad was purified by column chromatography on silica gel with petroleum ether / ethyl acetate as the eluent.

[0031] Or, Synthesis of Compound F

[0032]

[0033] According to the previous preparation literature report (Y. Yuan, Y. Zheng, B. Xu, et al., ACS Catal. 2020, 10, 6676-6681.), in a round-bottom flask (50 mL) equipped with a magnetic stirrer, para-substituted benzaldehyde (0.58 mL, 5.0 mmol) and NaHSO3 (5.73 g, 55.0 mmol) were mixed in H2O (20.0 mL) and added. When the mixture reached reflux temperature, o-phenylenediamine (0.54 g, 5.0 mmol) was added. The resulting mixture was stirred for 3 hours. After the reaction was completed, it was monitored by TLC analysis. After the reaction mixture was cooled to room temperature, it was vacuum filtered through a glass funnel. The residue was washed with water (20 mL × 2) and dried in an air drying oven to obtain the corresponding product F.

[0034] Synthesis of N-Methacryloyl-2-phenylbenzimidazole

[0035] To a solution of F (0.63 g, 3 mmol) and DMAP (73 mg, 0.6 mmol) in DCM (6 ml) was added Et3N (0.83 mL, 6 mmol). Methacryloyl chloride (0.58 mL, 6 mmol) was slowly dripped into the solution at 0°C. The solution was warmed to room temperature and stirred at room temperature for 12 hours. According to TLC analysis, the reaction was complete, and water (20 mL) was added to the mixture, which was extracted with DCM (15 mL×3). The organic solvent was then concentrated in vacuo. The residue was purified by flash column chromatography with ethyl acetate and petroleum ether as eluents to obtain 1ah. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 The following are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 1.

[0037] Figure 2 The following are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 6.

[0038] Figure 3 The following are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 8.

[0039] Figure 4 These are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 17.

[0040] Figure 5 These are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 19.

[0041] Figure 6 These are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 22.

[0042] Figure 7These are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 24.

[0043] Figure 8 These are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 26.

[0044] Fig. 9 These are the hydrogen and carbon nuclear magnetic resonance spectra of Example 27.

[0045] Fig.10 These are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 28.

[0046] Fig.11 These are the hydrogen and carbon nuclear magnetic spectra of the nuclear magnetic resonance instrument of Example 31.

[0047] Fig.12 This is the NMR spectrum of the NMR instrument of Example 32.

[0048] Fig.13 It is the NMR spectra of NMR instruments 3a and 3c in the application examples. DETAILED DESCRIPTION

[0049] The present invention is further described in detail in conjunction with the following specific examples, and the protection content of the present invention is not limited to the following examples. Without departing from the spirit and scope of the inventive concept, the changes and advantages that can be thought of by those skilled in the art are included in the present invention, and the attached claims are the scope of protection. The process, conditions, reagents, experimental methods, etc. for implementing the present invention, except for the contents specifically mentioned below, are all common knowledge and common common sense in the art, and the present invention has no special restrictions. The data given in the following examples include specific operations and reaction conditions and products. The purity of the product is identified by nuclear magnetic resonance and high-resolution mass spectrometry.

[0050] The experimental raw materials in the present invention were prepared under the following conditions with different substituents:

[0051] Synthesis of N-methacryloylbenzamide:

[0052]

[0053] According to the previous preparation literature report (J.Xu, Z.Yang, J.-W.Hua., Org.Chem.Front., 2020, 7, 3223-3228.), compound A was added with primary amine (15mmol), Et3N (20mmol) and DCM (20mL) in a 100mL round-bottom flask, the reaction mixture was cooled to 0°C, and then benzoyl chloride (10mmol) was slowly added dropwise. Stir at room temperature for 4-6 hours, then the reaction was completed under TLC monitoring, the organic phase was separated, dried over Na2SO4, and concentrated in vacuo. The obtained residue was purified by flash silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 1: 1) in a yield of 93-95%.

[0054] N-methylbenzamide (10 mmol), DMAP (1 mmol), triethylamine (20 mmol), and dichloromethane (20 mL) were added to a 100 mL round-bottom flask, and the reaction mixture was cooled to 0°C, and methacryloyl chloride was slowly added to the reaction mixture. Then, the mixture was stirred at room temperature for 4-6 hours, and the reaction was completed under TLC monitoring. The organic phase was separated, dried over Na2SO4, and concentrated in vacuo. The obtained residue was purified by flash silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 3:1) to obtain the desired product 1a in a yield of 74-85%.

[0055]

[0056] Or, Synthesis of Compound D:

[0057] According to the previous preparation literature report (Y. Yuan, Y. Zheng, B. Xu, et al., ACS Catal. 2020, 10, 6676-6681.), a mixture of substituted phenylhydrazine hydrochloride (2.0 mmol, 2.0 equiv) and acetic acid was added to a 250 mL round-bottom flask and stirred for 30 minutes under a N2 atmosphere at 50 ° C, and then the substituted ketone (1.0 mmol, 1.0 equiv) was added to the solution, heated to 130 ° C, and the reaction mixture was cooled after 8 hours of reaction. Water was added and the mixture was stirred at 0 ° C to obtain a precipitate. Then, the obtained crude solid indole compound D can be directly used in the next step of synthesis after drying. Sometimes, the obtained crude solid should be purified by column chromatography to obtain indole compound D.

[0058] Synthesis of 2-aryl-N-acryloyl indole:

[0059] According to the modified literature procedure, DCM (10 mL), indole D (5 mmol, 1 equiv) and DMAP (2.0 mmol, 0.4 equiv) were added to a 100 ml round-bottom flask and then Et3N (10 mmol, 2.0 equiv) was added to the mixed solution at 0 °C. Then, methacryloyl chloride (10 mmol, 2.0 equiv) was slowly dropped into the solution, and the solution was warmed to room temperature and stirred for 2-3 days. The mixture was diluted with DCM (20 mL) and saturated NH4Cl solution (20 mL). The organic layer and the aqueous layer were separated. The aqueous layer was extracted with DCM (20 mL × 3 times). The combined organic layers were washed with brine and dried over Na2SO4. After evaporation of the solvent, the crude product 1ad was purified by column chromatography on silica gel with petroleum ether / ethyl acetate as the eluent.

[0060] Or, Synthesis of Compound F

[0061]

[0062] According to the previous preparation literature report (Y. Yuan, Y. Zheng, B. Xu, et al., ACS Catal. 2020, 10, 6676-6681.), in a round-bottom flask (50 mL) equipped with a magnetic stirrer, para-substituted benzaldehyde (0.58 mL, 5.0 mmol) and NaHSO3 (5.73 g, 55.0 mmol) were mixed in H2O (20.0 mL) and added. When the mixture reached reflux temperature, o-phenylenediamine (0.54 g, 5.0 mmol) was added. The resulting mixture was stirred for 3 hours. After the reaction was completed, it was monitored by TLC analysis. After the reaction mixture was cooled to room temperature, it was vacuum filtered through a glass funnel. The residue was washed with water (20 mL × 2) and dried in an air drying oven to obtain the corresponding product F.

[0063] Synthesis of N-Methacryloyl-2-phenylbenzimidazole

[0064] To a solution of F (0.63 g, 3 mmol) and DMAP (73 mg, 0.6 mmol) in DCM (6 ml) was added Et3N (0.83 mL, 6 mmol). Methacryloyl chloride (0.58 mL, 6 mmol) was slowly dripped into the solution at 0°C. The solution was warmed to room temperature and stirred at room temperature for 12 hours. According to TLC analysis, the reaction was complete, and water (20 mL) was added to the mixture, which was extracted with DCM (15 mL×3). The organic solvent was then concentrated in vacuo. The residue was purified by flash column chromatography with ethyl acetate and petroleum ether as eluents to obtain 1ah.

[0065] Example 1

[0066]

[0067] Such as the synthesis of N-methacryloylbenzamide:

[0068] According to the previous preparation literature report (J.Xu, Z.Yang, J.-W.Hua., Org.Chem.Front., 2020, 7, 3223-3228.), compound A (the raw material R1 substituent in Example 1 is H) was added to a primary amine (15mmol), Et3N (20mmol) and DCM (20mL) in a 100mL round-bottom flask, and the reaction mixture was cooled to 0°C, and then benzoyl chloride (10mmol) was slowly added dropwise. Stir at room temperature for 4 hours, then the reaction was completed under TLC monitoring, the organic phase was separated, dried over Na2SO4, and concentrated in vacuo. The obtained residue was purified by flash silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 1: 1), and the yield was 93%.

[0069] N-methylbenzamide (10 mmol), DMAP (1 mmol), triethylamine (20 mmol), and dichloromethane (20 mL) were added to a 100 mL round-bottom flask, and the reaction mixture was cooled to 0°C, and methacryloyl chloride was slowly added to the reaction mixture. Then, the mixture was stirred at room temperature for 4-6 hours, and the reaction was completed under TLC monitoring. The organic phase was separated, dried over Na2SO4, and concentrated in vacuo. The obtained residue was purified by flash silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 3:1) to obtain the desired product 1a in a yield of 77%.

[0070] At room temperature and air atmosphere, N-methylacryloylbenzamide 1a (40.6 mg, 0.2 mmol), potassium selenocyanate (43.2 mg, 0.3 mmol), potassium persulfate (54.6 mg, 0.2 mmol), 2,4,6-triphenyl tetrafluoroborate (PC4) (0.8 mg, 0.002 mmol) and a mixed solvent of 1 mL of dichloromethane and 1 mL of water (volume ratio of 1:1) were added to a 10 mL quartz reaction tube with a stirring bar in sequence, and a 12 W blue light (465 nm) was used as a light source, and the reaction was stirred for 12 hours. After the reaction was completed, ethyl acetate was used for extraction (3×10 mL), the organic layers were combined, dried with Na2SO4, filtered, and the volatile components were removed under reduced pressure, and then separated by silica gel column chromatography (eluent was petroleum ether / ethyl acetate, v / v=3:1) to obtain the yellow solid target product 1a (54.8 mg, yield 89%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product were 2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2a): New compound. Yellow solid (54.8 mg, 89%); Mp: 96.4-96.9℃; 1 H NMR (600MHz, CDCl3) δ8.30(d,J=7.7Hz,1H),7.72(t,J=7.4Hz,1H),7.55(t,J=7.6Hz,1H),7.4 4(d,J=7.7Hz,1H),3.79(d,J=12.0Hz,1H),3.64(d,J=12.0Hz,1H),3.40(s,3H),1.78(s,3H). 13 C NMR(150MHz, CDCl3)δ175.51,163.66,140.22,134.83,129.76,128.90,125.29,124.81,101.91,47.90,38.09,30.04,27.60.HRMS(ESI)m / zCalcd for C 13 H 12 N2O2Se[M+H] + :309.0134,found:309.0136.

[0071] Example 2

[0072] The reaction steps and operating conditions were the same as those in Example 1, except that the reaction was carried out in the absence of light. The reaction was stopped and the target product 2a was not obtained after the same post-treatment as above, indicating that the reaction could not proceed without light.

[0073] Example 3

[0074] The reaction steps and operating conditions were the same as those in Example 1, except that the reaction was carried out without potassium persulfate. The reaction was stopped and the target product 2a (22.18 mg, yield 36%) was obtained by the same post-treatment as above. This indicates that potassium persulfate has an important influence on the system.

[0075] Example 4

[0076] The reaction steps and operating conditions were the same as those in Example 1, except that NaOCN was used instead of KSeCN. The reaction was stopped and the target product 2a was not obtained after the same post-treatment as above, indicating that KSeCN is a necessary condition.

[0077] Example 5

[0078] The reaction steps and operating conditions were the same as those in Example 1, except that the reaction was carried out without PC4. The reaction was stopped and the target product 2a (41.89 mg, yield 68%) was obtained by the same post-treatment as above. This indicated that PC4 had a certain influence on the system.

[0079] Example 6

[0080]

[0081] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 Me, R 2 The raw material 1b was obtained for Me with a yield of 78%. The difference in the reaction system is that the raw material added to the reaction system is 1b (43.42 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2b (36.4 mg, yield 59%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2,4,8-trimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2b): New compound. Yellow solid (36.4 mg, 59%); Mp: 131.7-132.5℃; 1H NMR (600MHz, CDCl3) δ7.54(t,J=7.7Hz,1H),7.32(d,J=7.6Hz,1H),7.30(d,J=7.9Hz,1H) ,3.78(d,J=12.1Hz,1H),3.64(d,J=12.1Hz,1H),3.35(s,3H),2.78(s,3H),1.75(s,3H). 13 C NMR (150MHz, CDCl3) δ175.26,164.08,143.48,141.41,133.52,132.76,123.3 1,123.07,102.50,47.80,38.11,30.48,27.55,23.96.HRMS(ESI)m / zCalcdfor C 14 H 14 N2O2Se[M+H] + :323.0293,found:323.0289.

[0082] Example 7

[0083]

[0084] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is para-substituted Me, R 2 The raw material 1c was obtained for Me with a yield of 85%. The difference between the reaction systems is that the raw material added to the reaction system is 1c (43.42 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2c (45.8 mg, yield 74%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2,4,6-trimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2c): New compound. White solid (45.8 mg, 71%); Mp: 132.5-132.9℃; 1 H NMR (600MHz, CDCl3) δ8.13(d,J=8.0Hz,1H),7.31(d,J=8.0Hz,1H),7.21(s,1H),3.7 6(d,J=12.1Hz,1H),3.63(d,J=12.1Hz,1H),3.34(s,3H),2.45(s,3H),1.74(s,3H). 13C NMR(150MHz, CDCl3)δ175.62,163.55,145.87,140.13,129.74,129.60,125.72,122.09,102.21,47.63,37.88,29.90,27.39,22.02.HRMS(ESI)m / zCalcd forC 14 H 14 N2O2Se[M+H] + :323.0293,found:323.0289.

[0085] Example 8

[0086]

[0087] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 Me, R 2 The raw material 1d was obtained for Me with a yield of 78%. The difference in the reaction system is that the raw material added to the reaction system is 1d (43.42 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain yellow solids 2d and 2d' (47.35 mg, yield 74%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2,4,7-trimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2d)+2,4,5-trimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2d'): New compound. Yellow siold(47.35 mg, 74%); Mp: 118.0-119.0℃; 1H NMR (600MHz, CDCl3) δ8.24 (dd, J=7.8, 1.1Hz, 0.24H), 8.06 (d, J=0.8Hz, 1H), 7.50 (dd, J=8.0, 1.4Hz,1H),7.47(d,J=0.9Hz,0.14H),7.42(t,J=7.7Hz,0.27H),7.31(d,J=8.0Hz,1H),3.98( d,J=12.4Hz,0.24H),3.93(d,J=12.4Hz,0.24H),3.76(d,J=12.1Hz,1H),3.60(d,J=12.1Hz,1 H),3.37(s,0.72H),3.35(s,3H),2.62(s,0.72H),2.43(s,3H),1.86(s,0.72H),1.72(s,3H). 13 C NMR (150MHz, CDCl3) δ176.16,175.57,163.82,163.74,139.22,138.92,137.28,137.05,135.66,135.6,129.70,128.70,128.49,12 5.85,125.14,124.44,102.08,101.08,49.31,47.45,38.08,35.69,29.91,27.72,27.49,26.85,22.62,21.07.HRMS(ESI)m / zCalcd for C 14 H 14 N2O2Se[M+H] + :323.0293,found:323.0288.

[0088] Example 9

[0089]

[0090] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is para-substituted Et, R 2The raw material 1e was obtained for Me with a yield of 79%. The difference in the reaction system is that the raw material added to the reaction system is 1e (46.2 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2e (48.4 mg, yield 72%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 6-ethyl-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2e): New compound. Yellow solid (48.4 mg, 72%); Mp: 83.0-83.8℃; 1 H NMR (600MHz, CDCl3) δ8.19(d,J=8.0Hz,1H),7.36(dd,J=8.1,1.0Hz,1H),7.22(d,J=0.7Hz,1H),3.78(d,J=12. 1Hz,1H),3.65(d,J=12.1Hz,1H),3.37(s,3H),2.76(q,J=15.2,7.6Hz,2H),1.75(s,3H),1.29(t,J=7.6Hz,3H). 13 C NMR (150MHz, CDCl3) δ175.82,163.65,152.06,140.27,129.87,128.62,124.56 ,122.36,102.31,47.82,37.89,30.10,29.32,27.48,15.10(s).HRMS(ESI)m / z Calcd for C 15 H 16 N2O2Se[M+H] + :337.0450,found:337.0438.

[0091] Example 10

[0092]

[0093] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 Para-substituted n Pr, R 2The raw material 1f was obtained for Me with a yield of 75%. The difference in the reaction system is that the raw material added to the reaction system is 1f (58.3 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2f (52.4 mg, yield 75%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2,4-dimethyl-6-propyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2f): New compound. White solid (52.4 mg, 75%); Mp: 99.0-99.4℃; 1 H NMR (600MHz, CDCl3) δ8.18(d,J=8.0Hz,1H),7.34(dd,J=8.1,1.1Hz,1H),7.20(s,1H),3.77(d,J=12.0Hz,1H) ,3.65(d,J=12.0Hz,1H),3.37(s,3H),2.69(t,J=7.7Hz,2H),1.75(s,3H),1.69(m,2H),0.96(t,J=7.3Hz,3H). 13 C NMR (150MHz, CDCl3) δ175.82,163.66,150.65,140.23 129.78,129.19,125.09,122.38,102.35,47.74,38.39,37.94,30.09,27.49,24.25,13.90.HRMS(ESI)m / z Calcd for C 16 H 18 N2O2Se[M+H] + :351.0606,found:351.0602.

[0094] Embodiment 11

[0095]

[0096] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 Para-substituted t Bu, R 21g of raw material was obtained for Me, with a yield of 75%. The difference in the reaction system is that 1g (58.3mg, 0.2mmol) of raw material was added to the reaction system instead of the reaction substrate (1a). The reaction was stopped under blue light (465nm) for 12 hours and then post-treated to obtain 2g of yellow solid (66.9mg, yield 92%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product were 6-(tert-butyl)-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dioe (2g): New compound. White solid (52.4mg, 75%); Mp: 99.0-99.4℃; 1 H NMR (600MHz, CDCl3) δ8.18(d,J=8.0Hz,1H),7.34(dd,J=8.1,1.1Hz,1H),7.20(s,1H),3.77(d,J=12.0Hz,1H) ,3.65(d,J=12.0Hz,1H),3.37(s,3H),2.69(t,J=7.7Hz,2H),1.75(s,3H),1.69(m,2H),0.96(t,J=7.3Hz,3H). 13 C NMR (150MHz, CDCl3) δ175.82,163.66,150.65,140.23 129.78,129.19,125.09,122.38,102.35,47.74,38.39,37.94,30.09,27.49,24.25,13.90.HRMS(ESI)m / z Calcdfor C 16 H 18 N2O2Se[M+H] + :351.0606,found:351.0602.

[0097] Example 12

[0098]

[0099] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 OMe is para-substituted, R 2The raw material 1h was obtained for Me with a yield of 82%. The difference in the reaction system is that the raw material added to the reaction system is 1h (46.6 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow oily liquid 2h (45 mg, yield 67%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 6-methoxy-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2h): New compound.Yellow oily liquid(45 mg, 67%); 1 H NMR (600MHz, CDCl3) δ8.20 (d, J=8.8Hz, 1H), 7.01 (dd, J=8.8, 2.3Hz, 1H), 6.85 (d, J=2.3Hz, 1H),3.89(s,3H),3.76(d,J=12.1Hz,1H),3.61(d,J=12.1Hz,1H),3.33(s,3H),1.73(s,3H). 13 C NMR(150MHz, CDCl3)δ175.57,164.66,163.19,142.41,131.95,117.43,114.53,110.51,102.31,55.86,47.90,37.81,29.99,27.34.HRMS(ESI)m / zCalcd forC 14 H 14 N2O3Se[M+H] + :339.0242,found:339.0238.

[0100] Embodiment 13

[0101]

[0102] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 F, R is para-substituted 2The raw material 1i was obtained for Me with a yield of 76%. The difference in the reaction system is that the raw material added to the reaction system is 1i (46.6 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2i (45.9 mg, yield 71%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 6-fluoro-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2i): New compound. Yellow solid (45.9 mg, 71%); Mp: 147.5-147.9℃; 1 H NMR (600MHz, CDCl3) δ8.30 (dd, J=8.8, 5.8Hz, 1H), 7.21 (ddd, J=15.3, 7.9, 2.4Hz, 1H), 7.14 (dd ,J=9.1,2.4Hz,1H),3.74(d,J=12.3Hz,1H),3.58(d,J=12.3Hz,1H),3.36(s,3H),1.76(s,3H). 13 C NMR (150MHz, CDCl3) δ174.87, 166.59 (d, J = 257.3Hz), 162.67, 143.15 (d, J = 9Hz), 132.72 (d, J = 10.5Hz), 121 .26(d,J=1.5Hz),116.72(d,J=21Hz),112.61(d,J=24Hz),101.35,48.05(d,J=1.5Hz),37.93,29.69,27.52. 19 F NMR(565MHz,CDCl3)δ-23.55.HRMS(ESI)m / zCalcd for C 13 H 11 FN2O2Se[M+H] + :327.0043,found:327.0039.

[0103] Embodiment 14

[0104]

[0105] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is para-substituted Cl, R 2The raw material 1j was obtained for Me with a yield of 76%. The difference in the reaction system is that the raw material added to the reaction system is 1j (47.4 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2j (52.8 mg, yield 77%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 6-chloro-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2j): New compound. Yellow solid (52.8 mg, 77%); Mp: 178.4-178.7℃; 1 H NMR(600MHz, CDCl3) δ8.24(d,J=8.5Hz,1H),7.52(dd,J=8.5,1.9Hz,1H),7.42(d,J=1 .9Hz,1H),3.76(d,J=12.3Hz,1H),3.58(d,J=12.3Hz,1H),3.39(s,3H),1.78(s,3H). 13 C NMR(150MHz, CDCl3)δ174.80,162.86,141.87,141.53,131.31,129.52,125.74,123.32,101.36,48.00,37.94,29.82,27.68.HRMS(ESI)m / zCalcd forC 13 H 11 ClN2O2Se[M+H] + :342.9747,found:342.9742.

[0106] Embodiment 15

[0107]

[0108] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 Br substituted at the phosphorus position, R 2The raw material 1k was obtained for Me with a yield of 78%. The difference in the reaction system is that the raw material added to the reaction system is 1k (56.2 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2k (12.1 mg, yield 16%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 8-bromo-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2k): New compound. Yellow solid (12.1 mg, 16%); Mp: 151.1-152.1℃; 1 H NMR (600MHz, CDCl3) δ7.85(d,J=7.9Hz,1H),7.50(t,J=7.9Hz,1H),7.44(d,J=7.8 Hz,1H),3.79(d,J=12.3Hz,1H),3.63(d,J=12.3Hz,1H),3.39(s,3H),1.77(s,3H). 13 C NMR(150MHz, CDCl3)δ174.39,161.63,143.17,136.64,134.31,124.99,124.87,123.40,102.13,48.68,37.58,30.63,28.20.HRMS(ESI)m / zCalcd for C 13 H 11 BrN2O2Se[M+H] + :386.9242,found:386.9232.

[0109] Example 16

[0110]

[0111] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is para-substituted Br, R 2The raw material 1l was obtained for Me with a yield of 75%. The difference in the reaction system is that the raw material added to the reaction system is 1l (56.2 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2l (46 mg, yield 61%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 6-bromo-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2l): New compound. Yellow solid (46 mg, 61%); Mp: 178.0-179.0℃; 1 H NMR (600MHz, CDCl3) δ8.15(d,J=8.4Hz,1H),7.68(dd,J=8.4,1.5Hz,1H),7.58(d,J=1 .4Hz,1H),3.76(d,J=12.3Hz,1H),3.58(d,J=12.3Hz,1H),3.38(s,3H),1.78(s,3H). 13 C NMR(150MHz, CDCl3)δ174.76,163.01,141.93,132.54,131.28,130.17,128.70,123.74,101.40,47.94,37.93,29.84,27.71.HRMS(ESI)m / zCalcd forC 13 H 11 BrN2O2Se[M+H] + :386.9242,found:386.9230.

[0112] Embodiment 17

[0113]

[0114] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is Br substituted at the meta position, R 2The raw material 1m was obtained for Me with a yield of 81%. The difference in the reaction system is that the raw material added to the reaction system is 1m (56.2 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and the yellow solid 2m (22.8 mg, yield 31%) and yellow solid 2m' (19 mg, 26%) were obtained after post-treatment. The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 7-bromo-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2m): New compound. Yellow solid (22.8 mg, 31%); Mp: 133.9-134.4℃; 1 H NMR (600MHz, CDCl3) δ8.36 (d, J=2.1Hz, 1H), 7.76 (dd, J=8.4, 2.1Hz, 1H), 7.25 (d, J=8 .4Hz,1H),3.72(d,J=12.2Hz,1H),3.52(d,J=12.2Hz,1H),3.33(s,3H),1.69(s,3H). 13 C NMR(150MHz, CDCl3)δ174.93,162.47,138.96,137.76,132.52,127.12,126.56,123.13,101.58,47.94,37.69,30.02,27.81.HRMS(ESI)m / zCalcd for C 13 H 11 BrN2O2Se[M+H] + :386.9242,found:386.9230.

[0115] 5-bromo-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2m'):New compound.Yellowsolid(19mg,26%); Mp:86.8-87.6℃ 1 H NMR (600MHz, CDCl3) δ8.43 (dd, J=7.9, 1.3Hz, 1H), 7.93 (dd, J=7.9, 1.3Hz, 1H), 7.42 (t, J=7.9Hz,1H),4.67(d,J=12.7Hz,1H),3.96(d,J=12.7Hz,1H),3.42(s,3H),2.03(s,3H). 13C NMR(150MHz, CDCl3)δ175.18,162.56,141.70,137.29,130.20,130.01,128.08,121.47,99.78,50.51,34.44,27.99,26.14.HRMS(ESI)m / zCalcd for C 13 H 11 BrN2O2Se[M+H] + :386.9242,found:386.9233.

[0116] Embodiment 18

[0117]

[0118] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is a para-substituted CF3, R 2 The raw material 1n was obtained for Me with a yield of 76%. The difference in the reaction system is that the raw material added to the reaction system is 1n (54.22 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2n (43.3 mg, yield 58%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2,4-dimethyl-4-(selenocyanatomethyl)-6-(trifluoromethyl)isoquinoline-1,3(2H,4H)-dione(2n): New compound. White solid (43.3 mg, 58%); Mp: 134.8-135.4℃; 1 H NMR (600MHz, CDCl3) δ8.44(d,J=8.2Hz,1H),7.80(d,J=8.3Hz,1H),7.69(s,1 H),3.80(d,J=12.4Hz,1H),3.63(d,J=12.4Hz,1H),3.41(s,3H),1.82(s,3H). 13 C NMR (150MHz, CDCl3) δ174.62, 162.59, 141.02, 136.27 (q, J = 33Hz), 130.61, 127.78, 125.73 ( q, J=3Hz), 123.21 (q, J=271.5Hz), 122.67 (q, J=4.5Hz), 100.94, 48.19, 37.89, 29.80, 27.80. 19F NMR(565MHz,CDCl3)δ14.69.HRMS(ESI)m / zCalcdfor C 14 H 11 FN2O2Se[M+H] + :377.0011,found:377.0003.

[0119] Embodiment 19

[0120]

[0121] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is disubstituted OMe, R 2 The raw material 1o was obtained for Me with a yield of 75%. The difference in the reaction system is that the raw material added to the reaction system is 1o (52.62 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2o (39.9 mg, yield 54%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 6,7-dimethoxy-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2o): New compound. White solid (39.9 mg, 54%); Mp: 153.9-154.4℃; 1 H NMR (600MHz, CDCl3) δ7.66(s,1H),6.76(s,1H),3.98(s,3H),3.95(s,3H),3.78(d,J=12.1Hz,1H),3.61(d,J=12.1Hz,1H),3.34(s,3H),1.72(s,3H). 13 C NMR (150MHz, CDCl3) δ175.87,163.33,154.69,149.49,134.21,117.62,110.54, 106.95,102.64,56.54,56.33,47.68,37.93,30.11,27.48.HRMS(ESI)m / zCalcd for C 15 H 16 N2O4Se[M+H] + :369.0348,found:369.0344.

[0122] Embodiment 20

[0123]

[0124] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 is trisubstituted OMe, R 2 The raw material 1p was obtained for Me with a yield of 78%. The difference in the reaction system is that the raw material added to the reaction system is 1p (58.62 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2p (26.5 mg, yield 34%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 5,6,7-trimethoxy-2,4-dimethyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2p): New compound. White solid (26.5 mg, 34%); Mp: 144.9-145.5℃; 1 H NMR (600MHz, CDCl3) δ7.61(s,1H),4.17(d,J=12.0Hz,1H),4.03(s,3H),3.94(s,3H),3.91(s,3H),3.78(d,J=12.0Hz,1H),3.35(s,3H),1.78(s,3H). 13 C NMR (150MHz, CDCl3) δ176.06,163.38,154.21,151.55,147.35,125.08,120.50,107 .05,100.90,61.16,60.83,56.24,48.25,36.65,27.59,27.19.HRMS(ESI)m / zCalcd for C 16 H 18 N2O5Se[M+H] + :399.0454,found:369.0452.

[0125] Embodiment 21

[0126]

[0127] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2The raw material 1q was obtained for Et with a yield of 83%. The difference in the reaction system is that the raw material added to the reaction system is 1q (43.42 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow oily liquid 2q (62.7 mg, yield 97%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2-ethyl-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2q): New compound. Yellow oily liquid (62.7 mg, 97%); 1 H NMR (600MHz, CDCl3) δ8.28(d,J=7.8Hz,1H),7.71(t,J=7.8Hz,1H),7.53(t,J=7.6Hz,1H),7.43(d,J=7.9Hz, 1H), 4.10-4.00 (m, 2H), 3.77 (d, J = 12.1Hz, 1H), 3.66 (d, J = 12.1Hz, 1H), 1.75 (s, 3H), 1.22 (t, J = 7.1Hz, 3H). 13 C NMR(150MHz, CDCl3)δ175.11,163.11,140.19,134.72,129.70,128.82,125.23,124.91,102.08,47.74,37.92,36.20,30.02,13.20.HRMS(ESI)m / zCalcd for C 14 H 14 N2O2Se[M+H] + :323.0293,found:323.0287.

[0128] Embodiment 22

[0129]

[0130] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2 for iPr obtained the raw material 1r with a yield of 76%. The difference in the reaction system is that the raw material added to the reaction system is 1r (46.23 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2l (46.4 mg, yield 69%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2-isopropyl-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2r): White solid (26.5 mg, 34%); Mp: 144.9-145.5℃; 1 H NMR (600MHz, CDCl3) δ7.61(s,1H),4.17(d,J=12.0Hz,1H),4.03(s,3H),3.94(s,3H),3.91(s,3H),3.78(d,J=12.0Hz,1H),3.35(s,3H),1.78(s,3H). 13 C NMR (150MHz, CDCl3) δ176.06,163.38,154.21,151.55,147.35,125.08,120.50,107 .05,100.90,61.16,60.83,56.24,48.25,36.65,27.59,27.19.HRMS(ESI)m / zCalcd for C 16 H 18 N2O5Se[M+H] + :399.0454,found:369.0452.

[0131] Embodiment 23

[0132]

[0133] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2 for nBu obtained the raw material 1s with a yield of 81%. The difference in the reaction system is that the raw material added to the reaction system is 1s (49.03 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2s (44.4 mg, yield 63%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2-butyl-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2s): New compound. Yellow solid (44.4 mg, 63%); MP: 108.8-109.3℃; 1 H NMR (600MHz, CDCl3) δ8.25(dd,J=7.9,1.2Hz,1H),7.68(t,J=7.8Hz,1H),7.51(t,J=7.7Hz,1H),7.43(d,J=7.9Hz,1H),4.01-3. 92(m,2H),3.76(d,J=12.1Hz,1H),3.66(d,J=12.1Hz,1H),1.73(s,3H),1.57(quin,2H),1.35(quin,2H),0.92(t,J=7.4Hz,3H). 13 C NMR (150MHz, CDCl3) δ175.23,163.21,140.12,134.61,129.60,128.70,125.18,124 .77,102.08,47.71,40.69,37.73,30.03,29.91,20.20,13.77.HRMS(ESI)m / zCalcd forC 16 H 18 N2O2Se[M+H] + :351.0606,found:351.0600.

[0134] Embodiment 24

[0135]

[0136] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2 for tBu obtained the raw material 1t with a yield of 76%. The difference in the reaction system is that the raw material added to the reaction system is 1t (49.03 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2t (23.5 mg, yield 35%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2-(tert-butyl)-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2t): New compound. Yellow solid (23.5 mg, 35%); MP: 139.4-140.4℃; 1 H NMR (600MHz, CDCl3) δ6.90 (dd, J=10.4, 3.1Hz, 1H), 6.62-6.58 (m, 2H), 6.52 (dd, J=10.1 ,1.7Hz,1H),3.55(d,J=12.4Hz,1H),2.95(d,J=12.4Hz,1H),1.63(s,3H),1.56(s,9H). 13 C NMR(150MHz, CDCl3)δ183.49,179.99,172.44,141.48,141.02,134.73,133.54,103.01,60.39,58.57,52.75,32.57,28.15,22.54.HRMS(ESI)m / zCalcd for C 16 H 18 N2O2Se[M+H] + :351.0606,found:351.0602.

[0137] Embodiment 25

[0138]

[0139] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2The raw material 1u was obtained for hexadecyl with a yield of 77%. The difference in the reaction system is that the raw material added to the reaction system is 1u (82.67 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow oily liquid 2u (46.4 mg, yield 45%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The obtained product parameters are 2-hexadecyl-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2u): New compound. Yellow oily liquid (46.5 mg, 45%); 1 H NMR (600MHz, CDCl3) δ8.28(d,J=7.8Hz,1H),7.70(t,J=7.4Hz,1H),7.53(t,J=7.6Hz,1H),7.43(d,J=7.9Hz,1H),4.02-3.93(m,2H), 3.77(d,J=12.1Hz,1H),3.67(d,J=12.1Hz,1H),1.75(s,3H),1.64-1.58(m,2H),1.32(br,5H),1.24(br,21H),0.86(t,J=6.8Hz,3H). 13 C NMR (150MHz, CDCl3) δ175.34,163.27,140.18,134.68,129.74,128.79,125.21,124.88,102.15,47.79,41.04,37.78,3 1.99,30.15,29.76,29.74,29.73,29.70,29.64,29.60,29.43,29.33,27.94,27.05,22.76,14.20.HRMS(ESI)m / zCalcd forC 28 H 42 N2O2Se[M+H] + :519.2484,found:519.2477.

[0140] Embodiment 26

[0141]

[0142] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2The raw material 1v was obtained for the cyclopropyl group with a yield of 82%. The difference in the reaction system is that the raw material added to the reaction system is 1v (45.82 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2v (37 mg, yield 55%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2-cyclopropyl-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2v): New compound. Yellow solid (37 mg, 55%); MP: 71.6-72.2℃; 1 HNMR (600MHz, CDCl3) δ8.24(dd,J=7.9,1.2Hz,1H),7.69(td,J=7.7,1.4Hz,1H),7.53-7.50(m,1H),7.41(d,J=7.9Hz,1H),3.74(d ,J=12.1Hz,1H),3.65(d,J=12.1Hz,1H),2.76-2.72(m,1H),1.70(s,3H),1.21-1.10(m,2H),0.81-0.76(m,1H),0.62-0.58(m,1H). 13 C NMR (150MHz, CDCl3) δ176.88,164.31,140.06,134.71,129.61,128.80,125.16 ,125.10,102.47,48.26,37.29,29.81,24.78,8.87,8.01.HRMS(ESI)m / zCalcd for C 15 H 14 N2O2Se[M+H] + :335.0293,found:335.0288.

[0143] Embodiment 27

[0144]

[0145] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2The raw material 1w was obtained for cyclohexyl with a yield of 80%. The difference in the reaction system is that the raw material added to the reaction system is 1w (54.23 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow oily liquid 2w (39.16 mg, yield 52%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 2-cyclohexyl-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2w): New compound. Yellow oily liquid (39.16 mg, 52%); 1 H NMR (600MHz, CDCl3) δ8.24 (dd, J=7.9, 1.2Hz, 1H), 7.68 (td, J=7.6, 1.4Hz, 1H), 7.5 2-7.49(m,1H),7.40(d,J=7.9Hz,1H),4.72(tt,J=12.2,3.7Hz,1H),3.73(d,J=12. 0Hz,1H),3.66(d,J=12.0Hz,1H),2.37-2.28(m,2H),1.85-1.82(m,2H),1.72(s,3H ),1.67-1.65(m,2H),1.60(d,J=12.4Hz,1H),1.41-1.31(m,2H),1.27-1.19(m,1H). 13 C NMR (150MHz, CDCl3) δ176.24,163.67,140.01,134.49,129.82,128.69,125.36,124.81,10 2.94,54.67,48.24,37.34,30.12,29.45,28.57,26.44,26.35,25.33.HRMS(ESI)m / zCalcd for C 15 H 14 N2O2Se[M+H] + :377.0763,found:377.0749.

[0146] Embodiment 28

[0147]

[0148] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2The raw material 1x was obtained for benzyl, and the yield was 82%. The difference in the reaction system was that the raw material added to the reaction system was 1x (55.83 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and the reaction was treated to obtain a white solid 2x (63 mg, yield 82%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product were 2-benzyl-4-methyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione (2x): New compound. White solid (63 mg, 82%); Mp: 131.7-132.3℃; 1 H NMR (600MHz, CDCl3) δ8.21(d,J=7.8Hz,1H),7.62(t,J=7.4Hz,1H),7.44(t,J=7.6Hz,1H),7.35(d,J=7.9Hz,1H),7.32(d,J=7.4 Hz,2H),7.21(t,J=7.3Hz,2H),7.16(t,J=6.8Hz,1H),5.10(s,2H),3.68(d,J=12.1Hz,1H),3.57(d,J=12.1Hz,1H),1.64(s,3H). 13 C NMR (150MHz, CDCl3) δ175.20,163.24,140.05,136.53,134.82,129.80,128.80,128.62,12 8.55,127.70,125.25,124.73,101.92,48.00,43.98,37.76,29.91.HRMS(ESI)m / zCalcdfor C 16 H 18 N2O2Se[M+H] + :385.0450,found:385.0441.

[0149] Embodiment 29

[0150]

[0151] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2The raw material 1y was obtained as benzylmethyl, with a yield of 79%. The difference in the reaction system is that the raw material added to the reaction system is 1y (58.63 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow oily liquid 2y (57.2 mg, yield 72%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The obtained product parameters are 4-methyl-2-(1-phenylethyl)-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2y): New compound. Yellow oily liquid (57.2 mg, 72%, dr = 1:1); 1 H NMR (600MHz, CDCl3) δ8.19-8.16(m,1H),7.62-7.59(m,1H),7.45-7.41(m,1H),7.33(dd,J=7.7,4.9Hz,1H) ,7.29(d,J=7.9Hz,2H),7.23(td,J=7.5,3.4Hz,2H),7.16-7.13(m,1H),6.19(dd,J=7.0,2.5Hz,0.5H),6.17 (dd,J=7.0,2.5Hz,0.5H),,3.64(d,J=12.1Hz,0.5H),3.60(d,J=12.1Hz,0.5H),3.58(d,J=12.1Hz,0.5H), 3.53(d,J=12.1Hz,0.5H),1.79(d,J=7.4Hz,1.5H),1.78(d,J=7.4Hz,1.5H),1.69(s,1.5H),1.52(s,1.5H). 13 C NMR (151MHz, CDCl3) δ175.35,175.20,163.36,163.28,140.12,139.95,139.93, 139.77,134.69,134.68,129.96,129.88,128.77,128.26,128.23,127.21,127.1 9,126.94,126.91,125.16,125.13,125.09,124.98,102.26,102.18,51.03,51. 00,48.64,48.35,37.69,36.93,30.21,29.85,16.35,16.09.HRMS(ESI)m / zCalcd for C 20 H 18 N2O2Se[M+H] +:399.0606,found:399.0600.

[0152] Embodiment 30

[0153]

[0154] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2 The raw material 1z was obtained for phenyl with a yield of 83%. The difference in the reaction system is that the raw material added to the reaction system is 1z (53.02 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2z (32.5 mg, yield 44%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 4-methyl-2-phenyl-4-(selenocyanatomethyl)isoquinoline-1,3(2H,4H)-dione(2z): New compound. Yellow solid(32.5 mg, 44%); Mp: 196.5-197.5℃; 1 HNMR (600MHz, CDCl3) δ8.34 (dd, J=7.9, 1.0Hz, 1H), 7.79 (td, J=7.7, 1.3Hz, 1H), 7.59 (t, J=7.7Hz, 1H), 7.53 (t, J=7. 2Hz, 3H), 7.47 (t, J = 7.3Hz, 1H), 7.21 (d, J = 7.4Hz, 2H), 3.82 (d, J = 12.2Hz, 1H), 3.77 (d, J = 12.2Hz, 1H), 1.90 (s, 3H). 13 C NMR (150MHz, CDCl3) δ175.68,163.57,140.27,135.22,134.81,130.18,129.60,129.1 8,129.09,128.35,125.45,124.98,101.97,48.68,37.78,30.41.HRMS(ESI)m / zCalcd for C 18 H 14 N2O2Se[M+H] + :371.0293,found:371.0287.

[0155] Embodiment 31

[0156]

[0157] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2 The raw material 1aa was obtained for methylbenzene with a yield of 76%. The difference in the reaction system is that the raw material added to the reaction system is 1aa (55.83 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2aa (29.9 mg, yield 38%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 4-methyl-4-(selenocyanatomethyl)-2-(p-tolyl)isoquinoline-1,3(2H,4H)-dione (2aa): New compound. Yellow solid (29.9 mg, 38%); Mp: 171.5-172.4℃; 1 H NMR (600MHz, CDCl3) δ8.33(dd,J=7.9,1.0Hz,1H),7.77(td,J=7.8,1.3Hz,1H),7.58(t,J=7.4Hz,1H),7.51(d,J=7.9Hz,1H ),7.32(d,J=8.0Hz,2H),7.10(d,J=8.2Hz,2H),3.80(d,J=12.2Hz,1H),3.76(d,J=12.2Hz,1H),2.42(s,3H),1.88(s,3H). 13 C NMR (150MHz, CDCl3) δ175.75,163.60,140.27,139.10,135.08,132.06,130.23,130.06,1 28.95,127.95,125.40,124.93,102.15,48.49,37.69,30.28,21.34.HRMS(ESI)m / zCalcd for C 19 H 16 N2O2Se[M+H] + :358.0450,found:358.0445.

[0158] Embodiment 32

[0159]

[0160] The reaction steps and operating conditions are the same as those in Example 1, except that the R 1 For H, R 2The raw material 1ab was obtained from trifluoromethylbenzene with a yield of 77%. The difference in the reaction system is that the raw material added to the reaction system is 1ab (66.61 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a yellow solid 2ab (14.1 mg, yield 15%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 4-methyl-4-(selenocyanatomethyl)-2-(4-(trifluoromethyl)phenyl)isoquinoline-1,3(2H,4H)-dione(2ab): New compound. Yellow solid (14.1 mg, 15%); Mp: 153.2-154.1℃ 1 H NMR (600MHz, CDCl3) δ8.34(d,J=7.1Hz,1H),7.82-7.78(m,3H),7.61(t,J=7.7Hz,1H),7.52(d,J =7.9Hz,1H),7.37(d,J=8.2Hz,2H),3.85(d,J=12.4Hz,1H),3.75(d,J=12.4Hz,1H),1.91(s,3H). 13 C NMR(150MHz,CDCl3)δ175.23,163.33,140.21,138.05,135.51,131.32(q,J=33Hz),13 0.20,129.23,126.69(q,J=3Hz),125.57,124.72,123.83(q,J=270Hz),122.92,101.27 48.94,37.89,30.41. 19 F NMR(565MHz,CDCl3)δ15.18.HRMS(ESI)m / zCalcd for C 19 H 16 N2O2Se[M+H] + :358.0450,found:358.0445.

[0161] Embodiment 33

[0162]

[0163] According to the previous preparation literature report (Y.Yuan, Y.Zheng, B.Xu, et al., ACS Catal.2020, 10, 6676-6681.), a mixture of substituted phenylhydrazine hydrochloride (2.0mmol, 2.0equiv) (the raw material R3 substituent in 33 of this embodiment is H) and acetic acid was added to a 250mL round-bottom flask and stirred for 30 minutes under N2 atmosphere at 50°C, and then the substituted ketone (1.0mmol, 1.0equiv) was added to the solution, heated to 130°C, and the reaction mixture was cooled after 8 hours of reaction, and water was added to stir the mixture at 0°C to obtain a precipitate. Then, the obtained crude solid indole compound D can be directly used in the next step of synthesis after drying. Sometimes, the obtained crude solid should be purified by column chromatography to obtain indole compound D.

[0164] Synthesis of 2-aryl-N-acryloyl indole:

[0165] According to the modified literature procedure, DCM (10 mL), indole compound D (5 mmol, 1 equiv) and DMAP (2.0 mmol, 0.4 equiv) were added to a 100 ml round-bottom flask, and then Et3N (10 mmol, 2.0 equiv) was added to the mixed solution at 0 °C. Then, methacryloyl chloride (10 mmol, 2.0 equiv) was slowly dropped into the solution, and the solution was heated to room temperature and stirred for 2-3 days. The mixture was diluted with DCM (20 mL) and saturated NH4Cl solution (20 mL). The organic layer and the aqueous layer were separated. The aqueous layer was extracted with DCM (20 mL × 3 times). The combined organic layers were washed with brine and dried over Na2SO4. After the solvent was evaporated, the crude product 1ac was purified by column chromatography on silica gel with petroleum ether / ethyl acetate as the eluent, and the yield was 75%. The difference in the reaction system was that the raw material added to the reaction system was 1ac (67.43 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then treated to obtain a white solid 2ac (85.7 mg, 92% yield). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product were 5-methyl-12-phenyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2ac): New compound. White solid (85.7 mg, 92%); Mp: 184.1-184.5℃; 1H NMR (600MHz, CDCl3) δ8.56(d,J=8.2Hz,1H),7.60-7.57(m,2H),7.55-7.52(m,3H),7.47(d,J=8.0Hz,1H),7.45-7.43(m,1H), 7.41(d,J=7.8Hz,1H),7.37-7.32(m,3H),7.12(t,J=7.6Hz,1H),3.92(d,J=11.9Hz,1H),3.82(d,J=11.9Hz,1H),1.88(s,3H). 13 CNMR (150MHz, CDCl3) δ171.76,135.72,134.17,133.480,132.37,130.11,129.48,129.14,128.82,128.49,128.05, 126.54,125.98,125.88,125.41,125.24,121.82,119.91,116.58,103.14,48.82,37.75,29.39.HRMS(ESI)m / zCalcd for C 25 H 18 N2OSe[M+H] + :443.0657,found:443.0653.

[0166] Embodiment 34

[0167]

[0168] The reaction steps and operating conditions are the same as those of Example 33, except that the R 3 The raw material 1ae was obtained as a substituted dimethyl with a yield of 76%. The difference in the reaction system is that the raw material added to the reaction system is 1ae (73.04 mg, 0.2 mmol) instead of the reaction substrate (1ac). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2ae (77.1 mg, yield 82%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 5,9,11-trimethyl-12-phenyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2ad): New compound. White solid (77.1 mg, 82%); Mp: 184.1-184.5℃; 1H NMR (600MHz, CDCl3) δ8.32(s,1H),7.58-7.55(m,1H),7.54-7.50(m,3H),7.44-7.42(m,1H),7.36(dd,J=7.9,0.7Hz,1H),7.30-7.27(m,1H),7.0 7(dd,J=8.2,1.1Hz,1H),7.04-7.01(m,1H),6.89(s,1H),3.89(d,J=11. 8Hz,1H),3.81(d,J=11.8Hz,1H),2.48(s,3H),1.92(s,3H),1.83(s,3H). 13 C NMR (150MHz, CDCl3) δ171.92,136.72,136.11,135.41,134.77,131.54,130.57,130.17,129.36,129.34,128.92,128.61,128.47, 128.32,128.03,127.60,125.83,125.72,125.61,122.80,114.73,103.47,48.68,37.83,29.59,21.88,19.78.HRMS(ESI)m / zCalcd forC 27 H 22 N2OSe[M+H] + :471.0970,found:471.0969.

[0169] Embodiment 35

[0170]

[0171] The reaction steps and operating conditions are the same as those of Example 33, except that the R 3Cl was used to obtain the raw material 1af with a yield of 76%. The difference in the reaction system was that the raw material added to the reaction system was 1af (74.22 mg, 0.2 mmol) instead of the reaction substrate (1ac). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2af (90.4 mg, yield 95%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product were 10-chloro-5-methyl-12-phenyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2ae): New compound. White solid (90.4 mg, 95%); Mp: 165.6-166.6℃; 1 H NMR (600MHz, CDCl3) δ8.47(d,J=8.7Hz,1H),7.58(t,J=7.0Hz,2H),7.55-7.52(m,1H),7.50(d,J=7.1Hz,2H),7.45(d,J=7.7Hz, 1H),7.41-7.35(m,3H),7.29(d,J=2.0Hz,1H),7.16-7.09(m,1H),3.90(d,J=11.9Hz,1H),3.80(d,J=11.9Hz,1H),1.87(s,3H). 13 C NMR (150MHz, CDCl3) δ171.69,135.89,133.82,132.89,132.51,131.07,130.13,130.08,129.68,129.58,128.81,1 28.24,126.59,126.16,126.02,125.09,120.92,119.58,117.71,102.67,48.94,37.90,29.45.HRMS(ESI)m / zCalcd for C 25 H 17 ClN2OSe[M+H] + :477.0267,found:477.0259.

[0172] Embodiment 36

[0173]

[0174] The reaction steps and operating conditions are the same as those of Example 33, except that the R 3The reaction system was different in that the raw material added to the reaction system was 1ag (81.01 mg, 0.2 mmol) instead of the reaction substrate (1ac). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2ag (33.6 mg, yield 33%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The product parameters were 8,9-dichloro-5-methyl-12-phenyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2af): New compound. Yellow oily liquid (33.6 mg, 33%). 1 H NMR (600MHz, CDCl3) δ7.58(t,J=6.7Hz,2H),7.54(dt,J=2.6,1.3Hz,1H),7.47(d,J=6.8Hz,2H),7 .42-7.38(m,4H),7.14-7.10(m,2H),3.88(d,J=12.2Hz,1H),3.77(d,J=12.2Hz,1H),1.96(s,3H). 13 C NMR (150MHz, CDCl3) δ172.11,136.49,134.62,133.15,132.93,132.54,131.25,130.33,130.07,129.75,129.61,1 28.80,128.20,127.10,125.99,125.96,125.45,120.53,118.84,103.20,50.68,36.88,28.83.HRMS(ESI)m / zCalcd for C 25 H 17 Cl2N2OSe[M+H] + :510.9877,found:510.9869.

[0175] Embodiment 37

[0176]

[0177] According to the previous preparation literature report (Y.Yuan, Y.Zheng, B.Xu, et al., ACS Catal. 2020, 10, 6676-6681.), in a round-bottom flask (50mL) equipped with a magnetic stirrer, the para-substituted benzaldehyde (the raw material R1 substituent in this example is H) (0.58mL, 5.0mmol) and NaHSO3 (5.73g, 55.0mmol) were mixed in H2O (20.0mL) and added. When the mixture reached reflux temperature, o-phenylenediamine (0.54g, 5.0mmol) was added. The resulting mixture was stirred for 3 hours. After the reaction was completed, it was monitored by TLC analysis, and the reaction mixture was cooled to room temperature and then vacuum filtered through a glass funnel. The residue was washed with water (20mL×2) and dried in an air-drying oven to obtain the corresponding product F.

[0178] Synthesis of N-Methacryloyl-2-phenylbenzimidazole

[0179] To a solution of F (0.63 g, 3 mmol) and DMAP (73 mg, 0.6 mmol) in DCM (6 ml) was added Et3N (0.83 mL, 6 mmol). Methacryloyl chloride (0.58 mL, 6 mmol) was slowly dripped into the solution at 0°C. The solution was warmed to room temperature and stirred at room temperature for 12 hours. According to TLC analysis, the reaction was complete, water (20 mL) was added to the mixture, and it was extracted with DCM (15 mL×3). The organic solvent was then concentrated in vacuo. The residue was purified by flash column chromatography with ethyl acetate and petroleum ether as eluents to obtain 1ah, i.e., substituent R 1 The raw material 1ah was obtained for H with a yield of 79%. The difference in the reaction system is that the raw material added to the reaction system is 1ag (52.42 mg, 0.2 mmol) instead of the reaction substrate (1a). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2ah (30.8 mg, yield 33%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 5-methyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2ag): New compound. White solid (30.8 mg, 53%); Mp: 116.9-117.3℃; 1H NMR (600MHz, CDCl3) δ8.53(d,J=7.6Hz,1H),8.31(d,J=7.2Hz,1H),7.84(d,J=7.3Hz,1H),7.65(t,J=7.2Hz, 1H),7.59(t,J=7.5Hz,1H),7.49-7.44(m,3H),3.92(d,J=12.3Hz,1H),3.78(d,J=12.3Hz,1H),1.88(s,3H). 13 C NMR (150MHz, CDCl3) δ171.47,149.19,144.24,138.31,132.60,131.21,129.32,126.76,126.58 ,126.21(d,J=6Hz),123.13,120.29,115.83,101.08,49.79,37.90,29.73.HRMS(ESI)m / zCalcd for C 18 H 13 N3OSe[M+H] + :368.0300,found:368.0300.

[0180] Embodiment 38

[0181]

[0182] The reaction steps and operating conditions are the same as those of Example 37, except that R 1 The raw material 1ai was obtained for Me with a yield of 81%. The difference in the reaction system is that the raw material added to the reaction system is 1ai (55.23 mg, 0.2 mmol) instead of the reaction substrate (1ah). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2ah (30.8 mg, yield 33%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 5-methyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2ah): New compound. White solid (40.4 mg, 53%); Mp: 135.1-135.6℃; 1H NMR (600MHz, CDCl3) δ8.40(d,J=8.0Hz,1H),8.28(d,J=7.6Hz,1H),7.81(d,J=7.6Hz,1H),7.47-7.41(m,2H), 7.39(d,J=7.9Hz,1H),7.26(s,1H),3.91(d,J=12.2Hz,1H),3.78(d,J=12.2Hz,1H),2.50(s,3H),1.87(s,3H). 13 C NMR (150MHz, CDCl3) δ171.70,149.45,144.31,143.46,138.31,131.18,130.31,126.70 (d,J=4.5Hz) ,126.50,125.96,120.39,120.12,115.74,101.40,49.67,37.76,29.77,22.13.HRMS(ESI)m / zCalcd for C 19 H 15 N3OSe[M+H] + :382.0453,found:382.0453.

[0183] Embodiment 39

[0184]

[0185] The reaction steps and operating conditions are the same as those of Example 37, except that the R selected in the preparation of the raw materials is 3 For H, R 1 The raw material 1aj was obtained from F with a yield of 79%. The difference in the reaction system is that the raw material added to the reaction system is 1aj (56.02 mg, 0.2 mmol) instead of the reaction substrate (1ah). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2aj (24.6 mg, yield 32%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 3-fluoro-5-methyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2ai): New compound. White solid (24.6 mg, 32%); Mp: 139.2-139.7℃; 1H NMR (600MHz, CDCl3) δ8.54(dd,J=8.7,5.7Hz,1H),8.29(d,J=7.3Hz,1H),7.82(d,J=7.3Hz,1H),7.48-7.43(m,2H),7 .30(td,J=8.5,2.3Hz,1H),7.17(dd,J=9.2,2.3Hz,1H),3.87(d,J=12.5Hz,1H),3.71(d,J=12.5Hz,1H),1.89(s,3H). 13 C NMR (150MHz, CDCl3) δ170.85, 165.26 (d, J = 253.5Hz), 148.43, 144.16, 140.93 (d, J = 7.5Hz), 131.10, 129.33 (d, J = 9.0Hz), 126.67,126.26,120.24,119.66(d,J=3.0Hz),117.33(d,J=22.5),115.79,113.55(d,J=24),100.55,49.98,37.81,29.49. 19 F NMR(565MHz,CDCl3)δ-104.54.HRMS(ESI)m / zCalcd for C 18 H 12 FN3OSe[M+H] + :386.0202,found:386.0204.

[0186] Embodiment 40

[0187]

[0188] The reaction steps and operating conditions are the same as those of Example 137, except that the R selected in the preparation of the raw materials is 3 For H, R 1The raw material 1ak was obtained for Cl with a yield of 80%. The difference in the reaction system is that the raw material added to the reaction system is 1ak (59.4 mg, 0.2 mmol) instead of the reaction substrate (1ah). The reaction was stopped under blue light (465 nm) for 12 hours and then post-treated to obtain a white solid 2ak (32.1 mg, yield 40%). The target product was confirmed by nuclear magnetic resonance and high-resolution mass spectrometry. The parameters of the obtained product are 3-chloro-5-methyl-5-(selenocyanatomethyl)indolo[2,1-a]isoquinolin-6(5H)-one(2ak): New compound. White solid(32.1 mg, 40%); Mp: 161.8-162.3℃; 1 H NMR (600MHz, CDCl3) δ8.46 (d, J=8.5Hz, 1H), 8.29-8.28 (m, 1H), 7.83-7.81 (m, 1H), 7.56 (dd, J=8 .4,1.9Hz,1H),7.49-7.44(m,3H),3.88(d,J=12.5Hz,1H),3.72(d,J=12.4Hz,1H),1.89(s,3H). 13 C NMR (150MHz, CDCl3) δ170.72,148.30,144.16,139.94,138.85,131.14,129.86,128.06,126.7 2,126.62,126.44,121.72,120.34,115.82,100.60,49.83,37.71,29.44.HRMS(ESI)m / zCalcd for C 18 H 12 ClN3OSe[M+H] + :401.9907,found:401.9906.

[0189] Application Examples

[0190]

[0191] In addition, a derivatization experiment of the target product 2a obtained in Example 1 was carried out to further demonstrate the synthetic application of this scheme. The product 2a (0.2 mmol), TMSCF3 (0.4 mmol) and Cs2CO3 (0.4 mmol) were reacted in a nitrogen atmosphere with acetonitrile as solvent for 15 hours. The SeCN group could be successfully converted into isoquinolinedione 3a containing a SeCF3 group with a yield of 94% (detected by nuclear magnetic resonance and high-resolution mass spectrometry), which can significantly enhance its lipophilicity and transmembrane permeability, thereby improving its biological activity (Q. Wang, Z. Qi, F. Xie and X. Li, Adv. Synth. Catal., 2015, 357, 355-360.). Trifluoromethylselenium (CF3Se) also shows valuable electronic properties, such as strong electron-withdrawing (Hamiett constant σp = 0.45, σm = 0.44) (C. Hansch, A. Leo, S. H. Unger, K. H. Kim, D. Nikaitani and E. J. Lien, J. Med. Chem., 1973, 16, 1207-1216; C. Hansch, A. Leo and R. W. Taft, Chem. Rev., 1991, 91, 165-195.), and the Hansch-Leo parameter (π = 1.29) recently measured by Billard reflects high lipophilicity (Q. Glenadel, E. Ismalaj and T. Billard, Eur. J. Org. Chem., 2017, 530-533.). In addition, product 2a (0.2 mmol), diethyl phosphate (0.4 mmol) and DBU (0.2 mmol) were reacted in toluene (2 mL) for 5 h to give 3b in quantitative yield (detected by nuclear magnetic resonance and high-resolution mass spectrometry).

[0192] The above descriptions are merely embodiments of the present invention and are not intended to limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made using the contents of the present invention specification and drawings, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.

Claims

1. A method for synthesizing selenocyanidin, characterized in that: N-(hetero)aryl acrylamide is used as a substrate, potassium selenocyanate and an oxidant as well as a bifunctional catalyst of photocatalysis and phase transfer catalysis are added, and the substrate is induced to synthesize a selenocyanated isoquinolinone compound under the condition of visible light.

2. The synthesis method according to claim 1, characterized in that: The N-(hetero)aryl acrylamide is N-aryl acryl benzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole compound, and the selenocyanated isoquinolinone compound is selenocyanated isoquinolinedione or 2-indole [2,1-a] isoquinolinone or benzimidazolo [2,1-a] isoquinolin-6 (5H) -one compound (III). The specific preparation process is: N-aryl acryloyl benzamide or 2-aryl-N-acryloyl indole or N-methacryloyl-2-phenylbenzimidazole compound and potassium selenocyanate are added with an oxidant and a bifunctional catalyst in a solvent, and a selenocyanide isoquinolinedione or 2-indole [2,1-a] isoquinolinone or benzimidazolo [2,1-a] isoquinolin-6 (5H) -one compound (III) is sequentially generated through a visible light induced reaction.

3. The synthesis method according to claim 1, characterized in that: The structure of N-aryl acryloyl benzamide is as follows: The structure of 2-aryl-N-acryloyl indole is as follows: The structure of N-methacryloyl-2-arylbenzimidazole is as follows: The structure of selenocyanidin isoquinolinone or indole[2,1-a]isoquinolinone or benzimidazolo[2,1-a]isoquinolin-6(5H)-one is as follows: Substituent R 1 is H, halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, fluoroalkyl C n F m H x , n is 1-4, m is 1-9, x is one or more of 0-8, the number of substituents is 1-5; halogen is one or more of F, Cl, Br or I; the substituent R 2 is an alkyl group having 1 to 4 carbon atoms, an alkyl group having 15 to 20 carbon atoms, a cycloalkyl group having 3 to 7 carbon atoms, a phenyl group, or an aryl group containing a substituent, wherein the substituent is an alkyl group or a fluoroalkyl group having 1 to 4 carbon atoms, a fluoroalkyl group C n F m H x , n is 1-4, m is 1-9, x is one or more of 0-8; the substituent R 3 It is one or more of H, CH3 or halogen, the halogen is one or more of F, Cl, Br or I, and the number of substituents is 1-5.

4. The synthesis method according to claim 1, characterized in that: The reaction is carried out under visible light of one or more of white light (6500K), violet light (400-405nm), blue light (460-465nm), green light (526-531nm) or red light (700-705nm), with 12W blue light (460-465nm) being the best.

5. The synthesis method according to claim 2, characterized in that: The solvent is one or more of acetonitrile, dichloromethane, water, dichloromethane / water (volume is 4:1-1:4), methanol, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, dimethyl sulfoxide and 1,2-dichloroethane. The preferred solvent is dichloromethane / water (volume is 1:1). The concentration of the N-(hetero)aryl acrylamide compound in the solvent is 0.1-1M, and the optimal concentration is 0.1-0.3M.

6. The synthesis method according to claim 1 or 2, characterized in that: The reaction is carried out in the presence of an oxidant, which is any one or two of N-chlorosuccinimide, dibenzoyl peroxide, oxygen, potassium persulfate, tert-butyl perbenzoate, and di-tert-butyl peroxide, and the preferred oxidant is potassium persulfate; the molar concentration of the oxidant in the solvent is 0.05-0.2M, preferably 0.125-0.2M, and most preferably 0.2M.

7. The synthesis method according to claim 1, 2 or 3, characterized in that: The reaction is carried out in the presence of a bifunctional catalyst, which is any one or more of PC1, PC2, PC3, and PC4, and the preferred bifunctional catalyst is PC2; the molar concentration of the bifunctional catalyst in the solvent is preferably 0.001-0.004M, and the optimal concentration is 0.001M.

8. The synthesis method according to claim 2, characterized in that: The preferred molar ratio of substrate to potassium selenocyanate (II) is 1:1-1:3, and the optimal molar ratio is 1:1.

5.

9. The synthesis method according to claim 1, 2 or 3, characterized in that: The reaction time under air atmosphere is 6-36 hours, and the optimal reaction time is 12 hours.

Citation Information

Patent Citations

  • Method for preparing fluoromethylated indole [2, 1, a] isoquinoline derivative by utilizing photocatalytic microchannel

    CN112979644A

  • Benzo [4, 5] imidazo [2, 1-a] isoquinoline-6 (5H)-ketone and derivative and preparation method thereof

    CN113480535A

  • Method for preparing alkylated indole [2, 1, a] isoquinoline derivative by using photocatalytic microchannel

    CN116283975A